HOME > Investors > Press Releases
2015-04-28
US FDA Approves VM202 for Phase III Clinical Study of Diabetic Peripheral Neuropathy (DPN)
2014-11-21
Disclosure of Clinical Trial Entry • Exit (Voluntary Disclosure)
2012-09-24
ViroMed announces final patient enrollment for VM202-PAD phase II clinical trial in US/Korea
2012-08-31
[Biospectrum. Aug. 2012] One drug for three diseases
2012-04-13
Approval from the Korea FDA for a Phase II clinical trial for diabetic peripheral neuropathy
11 12 13 14 15 16 17 18 19 20